These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1980421)

  • 1. The management of cardiac arrhythmias: The role of encainide and sotalol. A symposium. March 24-25, 1988. Proceedings.
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():531-634. PubMed ID: 1980421
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rational treatment of heart rhythm disorders. International symposium on "The Management of Cardiac Arrhythmias: the Role of Encainide and Sotalol". 24-25 March 1988, Wallingford (USA)].
    Fortschr Med Suppl; 1988; 43():1-22. PubMed ID: 2898424
    [No Abstract]   [Full Text] [Related]  

  • 3. A symposium: Encainide. January 24-25, 1986, Phoenix, Arizona.
    Am J Cardiol; 1986 Aug; 58(5):1C-116C. PubMed ID: 3092613
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pharmacology of antiarrhythmic agents.
    Kelliher GJ; Kowey P; Engel T; Wetstein L
    Cardiovasc Clin; 1985; 16(1):287-305. PubMed ID: 2874883
    [No Abstract]   [Full Text] [Related]  

  • 5. Encainide for cardiac arrhythmias.
    Med Lett Drugs Ther; 1987 May; 29(740):50-2. PubMed ID: 2437434
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of encainide in supraventricular arrhythmias.
    Pool PE
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():573-7. PubMed ID: 2125835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Special symposium: Improvement of Therapy of Cardiac Arrhythmias. Class III Antiarrhythmic Drugs Focussing on Sotalol and D-Sotalol. Nizza, 17-20 June 1992].
    Fortschr Med Suppl; 1992; 135():1-18. PubMed ID: 1358774
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequency.
    Duff HJ; Roden DM; Dawson AK; Oates JA; Smith RF; Woosley RL
    Am J Cardiol; 1982 Aug; 50(2):305-12. PubMed ID: 6808820
    [No Abstract]   [Full Text] [Related]  

  • 9. Sotalol in Life-Threatening Ventricular Arrhythmias: A Unique Class III Antiarrhythmic. Symposium proceedings. Phoenix, Arizona, September 19-22, 1991.
    Am J Cardiol; 1993 Aug; 72(4):1A-85A. PubMed ID: 8102220
    [No Abstract]   [Full Text] [Related]  

  • 10. Ventricular arrhythmias: risk stratification and approach to therapy after the Cardiac Arrhythmia Suppression Trial (CAST).
    Prystowsky EN; Katz A; Knilans TK
    Pacing Clin Electrophysiol; 1990 Nov; 13(11 Pt 2):1480-7. PubMed ID: 1702527
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1989 Jun; 261(23):3368. PubMed ID: 2498536
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of encainide and metabolizer phenotype on ventricular conduction during exercise.
    Karalis DG; Nydegger C; Porter RS; Carver J; Pina IL; Kutalek SP; Michelson EL
    Am J Cardiol; 1990 Dec; 66(19):1393-6. PubMed ID: 2123075
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for cardiac arrhythmias: new warning.
    Med Lett Drugs Ther; 1989 May; 31(792):48. PubMed ID: 2497313
    [No Abstract]   [Full Text] [Related]  

  • 14. Flecainide and CAST.
    Lancet; 1989 Aug; 2(8661):481-2. PubMed ID: 2570188
    [No Abstract]   [Full Text] [Related]  

  • 15. Class III Antiarrhythmic Drugs: Potential Impact on Arrhythmia Therapy. Symposium proceedings. Nice, France, 17 June 1992.
    Eur Heart J; 1993 Nov; 14 Suppl H():1-99. PubMed ID: 7904933
    [No Abstract]   [Full Text] [Related]  

  • 16. An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial.
    Coyle JD; Schaal SF
    DICP; 1989 Jun; 23(6):478-9. PubMed ID: 2500783
    [No Abstract]   [Full Text] [Related]  

  • 17. Encainide. A review of its pharmacological properties and therapeutic efficacy.
    Brogden RN; Todd PA
    Drugs; 1987 Nov; 34(5):519-38. PubMed ID: 3121275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from the cardiac arrhythmia suppression trial.
    Garratt C; Ward DE; Camm AJ
    BMJ; 1989 Sep; 299(6703):805-6. PubMed ID: 2510839
    [No Abstract]   [Full Text] [Related]  

  • 19. Newer antiarrhythmic drugs.
    Hess D
    West J Med; 1981 Apr; 134(4):333-41. PubMed ID: 6787808
    [No Abstract]   [Full Text] [Related]  

  • 20. CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1990 Mar; 11(3):194-9. PubMed ID: 2108031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.